(Q26471905)

title

Interventions for female pattern hair loss (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457957&resulttype=core&format=json

13 May 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457957&resulttype=core&format=json

13 May 2020

Esther J van Zuuren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457957&resulttype=core&format=json

13 May 2020

Johannes W. Schoones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457957&resulttype=core&format=json

13 May 2020

author name string

Esther J van Zuuren

1

0 references

Jan Schoones

Cochrane Database of Systematic Reviews

3

0 references

publication date

26 May 2016

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457957&resulttype=core&format=json

13 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457957&resulttype=core&format=json

13 May 2020

page(s)

CD007628

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457957&resulttype=core&format=json

Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Treatment of hyperandrogenic alopecia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

A pilot study evaluating the efficacy of topically applied niacin derivatives for treatment of female pattern alopecia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Topical estrogen therapy for androgenetic alopecia in menopausal females

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Therapeutic hotline. Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

The growth of human scalp hair in females using visible red light laser and LED sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Effect of a nutritional supplement on hair loss in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Quantitative estimation of hair growth. I. androgenetic alopecia in women: effect of minoxidil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Topical melatonin for treatment of androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Reversal of androgenetic alopecia by topical ketoconzole: Relevance of anti-androgenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Effects of topical application of growth factors followed by microneedle therapy in women with female pattern hair loss: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Ketoconazole shampoo: effect of long-term use in androgenic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Treatment of female pattern hair loss with oral antiandrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Low-level laser (light) therapy (LLLT) for treatment of hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

21 January 2018

Female pattern hair loss

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

How to formulate research recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

The psychology of hair loss and its implications for patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Development of a health-related quality of life questionnaire for women with androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Evaluation of androgen receptor gene as a candidate gene in female androgenetic alopecia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Prevalence of male and female pattern hair loss in Maryborough.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

TrichoScan. A new instrument for digital hair analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Effect of hairpieces on perceived quality of life in female pattern hair loss patients: questionnaire based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Decreased serum ferritin is associated with alopecia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Understanding and management of female pattern alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Guidelines for management of androgenetic alopecia based on BASP classification--the Asian Consensus Committee guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Follicular miniaturization in female pattern hair loss: clinicopathological correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Female pattern hair loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Evaluation and treatment of male and female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Androgenetic alopecia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Increased androgen receptor messenger RNA in frontal-parietal hair follicles of women with androgenetic alopecia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Medical treatments for male and female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

A system for rating the stability and strength of medical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Molecular mechanisms of androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Psychological characteristics of women with androgenetic alopecia: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Interventions for hirsutism (excluding laser and photoepilation therapy alone)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Androgenetic alopecia: an evidence-based treatment update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Treatment of female pattern hair loss with the androgen receptor antagonist flutamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Interventions for androgenic alopecia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Interventions for female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007628.PUB4

Nourkrin: objective and subjective effects and tolerability in persons with hair loss

21 January 2018

1 reference

12 December 2020

Therapeutic effects of minoxidil high extra combination therapy in patients with androgenetic alopecia

1 reference

12 December 2020

Treatment of female androgenetic alopecia with minoxidil 2%

1 reference

12 December 2020

Grading the quality of evidence and strength of recommendations: the GRADE approach to improving dental Clinical Guidelines.

1 reference

12 December 2020

1 reference

12 December 2020

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men.

1 reference

12 December 2020

Androgenetic alopecia: pathogenesis and potential for therapy.

1 reference

12 December 2020

Topical minoxidil in the treatment of androgenetic alopecia in women

1 reference

12 December 2020

Androgenetic alopecia: treatment results with topical minoxidil

1 reference

12 December 2020

Essential oils and low-intensity electromagnetic pulses in the treatment of androgen-dependent alopecia

1 reference

12 December 2020

Female pattern alopecia: current perspectives

1 reference

12 December 2020

Guidelines of care for androgenetic alopecia. American Academy of Dermatology

1 reference

12 December 2020

Female pattern hair loss: current treatment concepts

1 reference

12 December 2020

Characteristic features of Japanese women's hair with aging and with progressing hair loss

1 reference

12 December 2020

Current understanding of androgenetic alopecia. Part I: etiopathogenesis.

1 reference

12 December 2020

Androgenetic alopecia and current methods of treatment.

1 reference

12 December 2020

Thyroid hormone and hair growth

1 reference

12 December 2020

Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution

1 reference

12 December 2020

Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.

1 reference

12 December 2020

Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled, randomized double-blind study (author's transl)

1 reference

12 December 2020

The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females

1 reference

12 December 2020

A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.

1 reference

12 December 2020

Efficacy and tolerability of Hairgain in individuals with hair loss: a placebo-controlled, double-blind study

1 reference

12 December 2020

Treatment of female pattern hair loss

1 reference

12 December 2020

Systematic approach to hair loss in women.

1 reference

12 December 2020

Safety and efficacy of topical minoxidil in the management of androgenetic alopecia

1 reference

12 December 2020

The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women

1 reference

12 December 2020

Women who present with female pattern hair loss tend to underestimate the severity of their hair loss

1 reference

12 December 2020

Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women

1 reference

12 December 2020

Use of topical minoxidil therapy for androgenetic alopecia in women

1 reference

12 December 2020

Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies

1 reference

12 December 2020

Topical tretinoin for hair growth promotion

1 reference

12 December 2020

10.1002/14651858.CD007628.PUB4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457957&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457957&resulttype=core&format=json

13 May 2020

PubMed publication ID

27225981

1 reference